New Zealand's Greenfern exports medicinal cannabis to EU and UK under Ampyl's brand, CannFX.

New Zealand's Greenfern Industries and Ampyl Sciences announce the first export of Greenfern's export-quality medicinal cannabis flower to the EU and UK. The non-irradiated premium New Zealand cultivated strain will be sold under Ampyl's brand CannFX. Greenfern has sold its second harvested batch to Ampyl as part of a multi-year supply agreement, providing consistent cashflow for the Taranaki-based company.